| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0004 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0004 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0005 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0005 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.1 | 0.0005 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0005 |
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0005 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0006 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0006 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0006 |